The FDA said Friday that it will start taking action against compounders for violations in the next 60 to 90 days, depending on the type of facility, in order to "avoid unnecessary disruption to patient treatment." "Now that the FDA has determined the drug shortage for semaglutide has been resolved, we will continue to offer access to personalized treatments as allowed by law to meet patient needs," Hims & Hers CEO Andrew Dudum posted Friday on X
We understand that achieving and maintaining a healthy weight involves more than counting calories or following a diet plan
SURMOUNT trials demonstrated average weight loss of 22.5% in 72 weeks, compared to 2.4% for placebo
We treat your data confidentially and dont share any information with a third party.
There are several tips and tricks you can implement to assist with an effective and safe use of the medication
Review the published certificate for each listed strength, including its lot number and reported purity, potency, identity, heavy metals, sterility and endotoxin results